With the continuous approval of gene therapy products into the clinical research, the viral vectors which are used for gene therapy have attracted extensive attention. Adeno-associated virus is the most promising viral vector of many other viral vectors because of its low pathogenicity, low immunogenicity and the advantage of the host range and stable expression. It has gotten a wide range of applications in clinical research.
There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development.
This report contains market size and forecasts of AAV Vector Transfection Kits in global, including the following market information:
Global AAV Vector Transfection Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global AAV Vector Transfection Kits Market Sales, 2017-2022, 2023-2028, (Liter)
Global top five AAV Vector Transfection Kits companies in 2021 (%)
The global AAV Vector Transfection Kits market was valued at 83 million in 2021 and is projected to reach US$ 392.7 million by 2028, at a CAGR of 24.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Packaging Size Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of AAV Vector Transfection Kits include Thermo Fisher, Mirus Bio (Gamma), Polyplus-transfection, Polysciences, Takara and Hanbio Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the AAV Vector Transfection Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AAV Vector Transfection Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Liter)
Global AAV Vector Transfection Kits Market Segment Percentages, by Type, 2021 (%)
by Packaging Size
Small Size Packaging
Medium Size Packaging
Large Size Packaging
by Phase
Laboratory
GMP Phase 1-2
Global AAV Vector Transfection Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Liter)
Global AAV Vector Transfection Kits Market Segment Percentages, by Application, 2021 (%)
Suspension HEK 293 Cells
Adherent HEK 293 Cells
Others
Global AAV Vector Transfection Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Liter)
Global AAV Vector Transfection Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AAV Vector Transfection Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies AAV Vector Transfection Kits revenues share in global market, 2021 (%)
Key companies AAV Vector Transfection Kits sales in global market, 2017-2022 (Estimated), (Liter)
Key companies AAV Vector Transfection Kits sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Mirus Bio (Gamma)
Polyplus-transfection
Polysciences
Takara
Hanbio Biotechnology

LEAVE A REPLY

Please enter your comment!
Please enter your name here